Are we entering a booster-free era?
Expert discussion with Prof. José Gatell and Dr. Marta Boffito
Why Boost Today?
Why did we begin to boost antiretroviral agents?
What are the drawbacks of boosting agents?
How similar are ritonavir and cobicistat?
Which patients would benefit from a booster free approach?
Advantages of booster-free dolutegravir▼ –based regimens
TRIUMEQ is indicated for the treatment of HIV-infected adults and adolescents above 12 years of age weighing at least 40 kg.
Before initiating treatment with abacavir-containing products, HLA-B*5701 status must always be documented. Abacavir should not be used in patients known to carry the HLA-B*5701 allele due to the risk of hypersensitivity reaction.
Tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infected adults, adolescents and children above 6 years of age.
For further information on Triumeq and Tivicay please visit: Summary of Product Characteristics.